Continuous live cell sequencing (Liveseq GEN2)

Research unit

INNOSUISSE

Project number

128.644 IP-LS

Project title

Continuous live cell sequencing (Liveseq GEN2)

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Biotechnology and processing
Abstract (English)	Next-generation live-seq platform combining EPFL's expertise with Cytosurge's FluidFM technology. Delivers a technological breakthrough culminating in a 70X throughput improvement, enabling radical business transformation from niche equipment provider into a data-driven life-science company.